Patient Guide: Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 139 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05043090
Status: ACTIVE_NOT_RECRUITING
Condition: Papillary Renal Cell Carcinoma
Phase: PHASE3

Find a Study Location Near You

This study is available at 139 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Boston, Massachusetts
  • New York, New York
  • Buenos Aires,
  • • And 136 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily